Press Release titled "Biocon Q1FY20 Revenue Rs. 1 490 Cr Up 25%; EBITDA Up 51% at Rs. 462 Cr; Net Profit (excluding exceptional item) Up 86% at Rs. 223 Cr Small Molecules up 20% at Rs. 480 Cr Biologics Up 96% at Rs. 490 Cr"
25-Jul-2019
Download PDF
Biocon
Press Release titled "Biocon Q1FY20 Revenue Rs. 1 490 Cr Up 25%; EBITDA Up 51% at Rs. 462 Cr; Net Profit (excluding exceptional item) Up 86% at Rs. 223 Cr Small Molecules up 20% at Rs. 480 Cr Biologics Up 96% at Rs. 490 Cr"